A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

Autor: Marion Münster, Jurgen A Riedl, Anthonius Dofferhof, Joachim Linssen, Jarob Saker, Mathie P. G. Leers, Annelies Verbon, Henk Russcher, Yvette Kluiters-de Hingh, Volkher Scharnhorst, Lucas Joost Van Pelt, André J. A. M. van der Ven, Marvin A.H. Berrevoets, Judith M.E.P. Gillis, Giulia Previtali, Simone van der Sar-van der Brugge, Imke C. A. Munnix, Michela Seghezzi, Stephan J. L. Bakker, Anthony Ermens, Heidi S. M. Ammerlaan, Eva de Jongh, Kathleen Deiteren
Přispěvatelé: Clinical Chemistry, Internal Medicine, Groningen Institute for Organ Transplantation (GIOT), Groningen Kidney Center (GKC)
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
complete blood count
Prognostic score
Cohort Studies
0302 clinical medicine
Symptom duration
Medicine
Clinical severity
Biology (General)
intensive care
Aged
80 and over

medicine.diagnostic_test
General Neuroscience
Complete blood count
General Medicine
Middle Aged
Prognosis
Hospitals
prognostic score
Europe
Hospitalization
030220 oncology & carcinogenesis
Female
Cell activation
Research Article
Human
Adult
medicine.medical_specialty
Adolescent
Coronavirus disease 2019 (COVID-19)
QH301-705.5
Science
CORONAVIRUS DISEASE 2019
PERIPHERAL-BLOOD
DIAGNOSIS
General Biochemistry
Genetics and Molecular Biology

ROUTINE
Hospital based study
03 medical and health sciences
Young Adult
All institutes and research themes of the Radboud University Medical Center
Intensive care
Internal medicine
Humans
haemocytometry
Pandemics
Biology
Aged
Retrospective Studies
General Immunology and Microbiology
SARS-CoV-2
business.industry
COVID-19
Blood Cell Count
030104 developmental biology
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4]
CELLS
Observational study
Human medicine
business
Zdroj: eLife
Elife, 9
eLife, 9:e63195, 1-37. eLife Sciences Publications
eLife, 9. ELIFE SCIENCES PUBLICATIONS LTD
eLife, 9:63195. ELIFE SCIENCES PUBLICATIONS LTD
eLife, Vol 9 (2020)
ISSN: 2050-084X
DOI: 10.7554/elife.63195
Popis: COVID-19 induces haemocytometric changes. Complete blood count changes, including new cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European hospitals were retrospectively analysed for distinctive patterns based on age, gender, clinical severity, symptom duration and hospital days. The observed haemocytometric patterns formed the basis to develop a multi-haemocytometric-parameter prognostic score to predict, during the first three days after presentation, which patients will recover without ventilation or deteriorate within a two-week timeframe, needing intensive care or with fatal outcome. The prognostic score, with ROC curve AUC at baseline of 0.753 (95% CI 0.723-0.781) increasing to 0.875 (95% CI 0.806-0.926) on day 3, was superior to any individual parameter at distinguishing between clinical severity. Findings were confirmed in a validation cohort. Aim is that the score and haemocytometry results are simultaneously provided by analyser software, enabling wide applicability of the score as haemocytometry is commonly requested in COVID-19 patients.
Databáze: OpenAIRE